| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Dale Broadrick last filed a Form 4 in October 2024, as 10% Owner at BRTX. From February 2019 to October 2024, the filings on record show 29 open-market purchases and 4 sales. Dale Broadrick's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Dale Broadrick a middling insider score of 60/100, based on 45 past trades. Over a 12-month horizon, 55.6% of those trades were profitable, with an average 12-month return of +3.4%.
At the last filing, the largest reported position was 445,933 shares of BRTX. Net of sales, the BRTX filings show accumulation of 16,782,982 shares.
Shares as reported in the last Form 4 for each company; the most recent is from October 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 17, 2019 | BRTX Biorestorative Therapies, Inc. | 10% Owner | Buy | 3,798,400 | $0.17 | $643,004.02 | +105.0% | |
| Aug 22, 2019 | BRTX Biorestorative Therapies, Inc. | 10% Owner | Buy | 175,017 | $0.28 | $49,164.28 | +5.1% | |
| May 7, 2019 | BRTX Biorestorative Therapies, Inc. | 10% Owner | Buy | 1,278,060 | $0.47 | $606,656.75 | +59.1% |